Peregrine Pharmaceuticals (PPHM) Tops Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts PPHM Hot Sheet
Join SI Premium – FREE
Peregrine Pharmaceuticals (NASDAQ: PPHM) reported Q3 EPS of ($0.04), $0.03 better than the analyst estimate of ($0.07).
For earnings history and earnings-related data on Peregrine Pharmaceuticals (PPHM) click here.
For earnings history and earnings-related data on Peregrine Pharmaceuticals (PPHM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rivian reports record Q3 deliveries, beats estimates, shares rise
- Cuprina to buy seven-clinic Singapore healthcare group for S$4M
- Robinhood shares climb on summit momentum and analyst support
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
